Calderasib

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameCalderasib
Drug Alias NameMK-1084
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKRAS G12C inhibitors
TargetsKRAS G12C
Therapy Area/IndicationsSolid tumoursRenal InsufficiencyHepatic Insufficiency +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumBulgariaCanada +[50] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesLonza Bend IncWerthenstein Biopharma GmbhMerck Sharp & Dohme Corp +[6] 
Inactive CompaniesN/A
Active IndicationsSolid tumoursRenal InsufficiencyHepatic Insufficiency +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A